Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients
1990 (English)In: Journal of Internal Medicine, ISSN 0954-6820, E-ISSN 1365-2796, Vol. 228, no 2, 103-113 p.Article in journal (Refereed) Published
A prospective study has been performed on 84 patients with endocrine pancreatic tumours evaluated at the Medical Department in Uppsala. Available information concerning the patients' presenting symptoms, age at diagnosis, clinical syndrome, tumour location, location of metastases, diagnostic radiology, biochemical and histopathological findings has been analysed. Our results indicate that most patients initially show rather vague and non-specific symptoms, with dyspepsia and pain being the most frequent presenting features. The median delay between appearance of the first symptom and diagnosis was 2 years; the delay was 3 5 months in sporadic cases and 14.5 months in familial cases. In spite of improvements in diagnostic methods, the median age at diagnosis (53 years) has not been reduced, and most patients are encountered when the tumour has reached an advanced stage. There is a need for a method of screening patients with still uncharacteristic abdominalsymptoms for a neuroendocrine tumour. The presence of elevated levels of plasma chromogranin in all patients with a proven tumour suggests that such possibilities exist, and the use of this biochemical marker in the future might reduce the age at diagnosis and thus improve the likelihood of cure and survival of patients with endocrine pancreatic tumours.
Place, publisher, year, edition, pages
1990. Vol. 228, no 2, 103-113 p.
chromogranins, clinical syndrome;malignancy, neuroendocrine pancreatic tumours, tumour markers
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-150946DOI: 10.1111/j.1365-2796.1990.tb00202.xOAI: oai:DiVA.org:uu-150946DiVA: diva2:409438